Name | 2-chloro-6-methyl-N'-{4-methyl-3-[(quinolin-3-yl)ethynyl]benzoyl}benzohydrazide |
Synonyms | K0706 Vodobatinib Vodobatinib (SCO-088, SUN-K706 2-Chloro-6-methyl-N'-(4-methyl-3-(quinolin-3-ylethynyl)benzoyl)benzohydrazide N'-(2-chloro-6-methylbenzoyl)-4-methyl-3-[2-(3-quinolyl)ethynyl]-benzohydrazide 2-chloro-6-methyl-N'-{4-methyl-3-[(quinolin-3-yl)ethynyl]benzoyl}benzohydrazide Benzoic acid, 2-chloro-6-methyl-, 2-[4-methyl-3-[2-(3-quinolinyl)ethynyl]benzoyl]hydrazide |
CAS | 1388803-90-4 |
Molecular Formula | C27H20ClN3O2 |
Molar Mass | 453.92 |
Density | 1.35±0.1 g/cm3(Predicted) |
Boling Point | 748.6±60.0 °C(Predicted) |
Solubility | Soluble in DMSO |
pKa | 10.09±0.23(Predicted) |
Storage Condition | -20℃ |
Use | Vodobatinib is a tyrosine kinase inhibitor and antineoplastic。 |
Reference Show more | 1: WHO Drug Information, Vol. 34, No. 2, 2020 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.203 ml | 11.015 ml | 22.03 ml |
5 mM | 0.441 ml | 2.203 ml | 4.406 ml |
10 mM | 0.22 ml | 1.102 ml | 2.203 ml |
5 mM | 0.044 ml | 0.22 ml | 0.441 ml |